Delivery Order SPE2DH25D0001-SPE2D426F4227
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,130.88 on August 29, 2025, by the Defense Logistics Agency's Medical Supply Chain organization. This fixed-price delivery order with economic price adjustment features a completion date of September 3, 2025, and will be performed at Abbott's facility in North Chicago, Illinois. The contract pertains to cartridge analysis and testing components, consistent with Abbott's core business...
- Abbott Laboratories Inc.'s Abbott Point of Care division was awarded a $1,926 delivery order on December 16, 2025, by the Defense Logistics Agency Medical Supply Chain for chemistry test cartridges and analytical testing supplies. The firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, will be performed in North Chicago, Illinois, and represents a continuation of Abbott's long-standing relationship as a primary federal supplier of diagnostic and...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,665.00 on December 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment authority (Contract No. 4570184201) is for cartridges, chemistry test analysis supplies, with performance of work occurring in North Chicago, Illinois. The award was made without any small business set-aside provision and is...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,203.39 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for cartridge chemistry 8-25 test analysis supplies. This fixed-price delivery order with economic price adjustment, which is scheduled for completion by November 3, 2025, was issued without a small business set-aside and will be performed at Abbott's North Chicago, Illinois location. The award represents a...
- Abbott Laboratories Inc.'s Abbott Point of Care division received a delivery order award valued at $1,395.94 from the Defense Logistics Agency Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 12, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, covers cartridge chemistry testing and analysis supplies (CRTDG CHM 8 25 TST ANLY). Performance will be conducted at Abbott's North Chicago, Illinois...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,969.38 on December 19, 2025, with an ultimate completion date of December 22, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Logistics Agency Medical Supply Chain for the procurement of cartridge chemistry 8 25 test analysis products. The award was made to North Chicago, Illinois-based Abbott without a set-aside designation, utilizing full...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,249.50 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with completion scheduled for July 17, 2025. The contract utilizes firm fixed pricing and does not include a set-aside designation, indicating full and open competition. The award covers cartridge chemistry testing and analytical supplies, with performance to be completed at Abbott's North Chicago,...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a fixed-price delivery order with economic price adjustment on November 9, 2025, with a ceiling value of $2,767.09 and ultimate completion date of November 12, 2025. The delivery order, issued by the Defense Logistics Agency Medical Supply Chain, pertains to chemistry test cartridges and analytical supplies (reference number 4569961790). The contract was awarded without a set-aside designation, reflecting full and...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,307.09 on December 8, 2025, by the Defense Logistics Agency Medical Supply Chain for cartridge chemistry testing analytical supplies. This fixed-price contract with economic price adjustment carries a completion date of January 29, 2026, and will be performed in North Chicago, Illinois. The award utilized full and open competition with no small business set-aside. As a child entity of...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,719.63 by the Medical Supply Chain, a defense-focused federal agency, on August 18, 2025. This fixed-price contract with economic price adjustment calls for cartridge chemistry 8-25 test analysis supplies, with performance to be completed at Abbott's facility in North Chicago, Illinois, by September 2, 2025. The contract was awarded on a full and open competition basis with no set-aside...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D426F4227Delivery Order
Abbott Laboratories Inc.'s Abbott Point of Care division received a $5,093.94 fixed-price delivery order from the Defense Logistics Agency Medical Supply Chain on December 25, 2025, for chemistry cartridges and eight test analysis supplies, with completion scheduled for December 29, 2025. This delivery order, issued without set-aside designation, supports the federal government's medical supply chain operations at the North Chicago, Illinois location. The award leverages Abbott's established position as a primary federal supplier of diagnostic and point-of-care testing products, particularly through its extensive portfolio of indefinite delivery vehicles and blanket purchase agreements across multiple Veterans Integrated Service Networks and Defense Health Agency contracts. This delivery order represents a routine procurement under Abbott's established indefinite delivery infrastructure, which collectively spans tens of millions of dollars across GSA Schedules FSS-66-III (Critical Analyzers, Laboratory) and FSS-65-VII (In-Vitro Diagnostics, Reagents, Test). Abbott's federal contracting approach emphasizes fixed-price structures with cost-per-reportable-result or cost-per-test pricing models that enable efficient government procurement of its diagnostic and medical technologies. The company's comprehensive contract portfolio encompasses clinical laboratory analyzers, point-of-care testing devices including i-STAT portable blood analyzers, and specialized diagnostic reagents and consumables, serving as a critical supplier to federal healthcare agencies including the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 12/24/25 |